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Abstract. This paper presents the results of the analysis of the
distribution of allelic polymorphism of interleukin-1beta gene, -8,
receptor antagonist and interleukin-1-induced NO-synthase in
children of Chernivtsi region suffering from stomach ulcer and
duodenal ulcer and healthy ones. It has been established that
susceptibility to peptic ulcer disease is associated with the presence
of the following genotypes: IL-1β-511C/C, R4/R4 IL-1Ra, IL-8-251A/T
and C/C G954C in the promoter area of the gene induced NO-
synthase.
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Introduction
Diseases of the digestive system have always
been in the focus of doctors because of high
prevalence, course and feature of a high risk of early
disability. Peptic ulcer disease (PUD) due to the
increasing frequency and its leading place in the
structure of diseases of gastroduodenal region is of
the most social and health value among them [12].
Modern understanding of the formation and
development of PUD are based on generalizing the
concept of an imbalance between factors of aggre-
ssion and defense, and are discussed in the context of
the persistence of H. pylori [2]. A key element in the
development of ulcer is not only lasted H. pylori
infection in the organism, but also intimately involved
in the process cells of immune system [3].
Disregulation mechanisms of the immune res-
ponse of the macroorganism are associated with the
direct cytopathic effect of H. pylori that potentiates
the synthesis of proinflammatory cytokines -
important factors of mucosa membrane damage
(MM) of the stomach and duodenum (DU) and
causes reorganization of its cells, manifested by
expression of genes responsible for the synthesis of
interleukin [4]. Effects of cytokines on the one hand,
is inappropriate activation of the immune system
(increased apoptosis of immune cells with subsequent
elimination), and on the other hand - the imbalance
between the processes of programmed death of
epithelial cells and their proliferation [7]. Increased
cell death contributes to the development of ulcers of
the stomach and duodenum [2].
Infection of the stomach and duodenum H. pylori
enhances expression induced NO-synthase (i-NOS),
which regulates the action of one of the most
important biological mediators parietal cells of the
stomach - nitric oxide (NO) [9]. The latter belong to
the most important factors of protection of the sto-
mach and duodenum, which supports an active
vasodilation, regulates basal blood flow and blood
pressure [1, 13].
A large amount of data as to involvement of dif-
ferent polymorphic genes of interleukins and i-NOS
and susceptibility to the formation of many socially
significant diseases associated with long-term persis-
tence of the pathogen, that determines the course of
the disease and the occurrence of complications [7,
10].
Taking into account non mono semantic data the
role of specific gene polymorphisms of interleukins
and i-NOS in the development of helicobacter-po-
sitive ulcer, the priority is to study association of the
disease with a number of allelic variants of poly-
morphic genes of interleukins, i-NOS and their
receptors in children.
Objective
To analyze the significance of allelic polymor-
phism of interleukin-1beta gene, -8, receptor anta-
gonist and interleukin-1 gene, induced NO-synthase
in the development and course of peptic ulcer
disease in children.
Material and methods
The study involved 120 children aged 7-18 years,
patients with ulcer (group under study) and 100 heal-
thy children of appropriate age (comparative group).
The average age of the children was 12,6 ± 3,2
years. Children in both groups are Ukrainians, living in
Chernivtsi and Chernivtsi region. Verification of
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clinical diagnosis of PUD was conducted in accor-
dance with protocol of the specialty "Pediatric
Gastroenterology" (Ministry of Health Care of Uk-
raine ¹ 59 of 29.01.2013 year) on the basis of
clinical, endoscopic (using endoscopic "Pentax FG-
24P", according to "the Sydney system" (1990) taking
into account the specifics of the study in children
(S.Ya. Doletskyy, 1984) and morphological (holding
MM biopsy under general rules on assessment of
morphological changes of MM according to the
"Sydney-Houston system" in sections, hematoxylin
and eosin painted using a visual analogue scale semi-
quantitative assessment of morphological changes
(M.F. Dixon, 1996) in points (0-3 degrees of severity)
according five criteria: the severity of chronic inflam-
mation, its activity, sowing H. pylori, the presence of
atrophy and intestinal metaplasia). Studies of acid
production functions of the stomach were performed
using a pH-meter "IKSH 2". H. pylori infection
confirmed by brush biopsy ("the Sydney-Houston
system", 1996) with the preparation of smears for
cytoscopic study to determine H. pylori and its deg-
ree of sowing by L.I. Aruin (1998); ELISA for the
conventional method using diagnostic test kits
"HelikoBest antibodies" (set of reagents for "Vector
BEST" (Russian Federation)) with the detection of
antibodies to CagA H. pylori antigen in serum.
Study of gene polymorphism of interleukin IL-1β-
511C/T, IL-8-251A/T, IL-1Ra VNTR and i-NOS
was performed by restriction analysis of amplification
products specific areas of the genome. Analysis of
amplificative products was performed by electro-
phoresis in 3% agarose gel with etydium-bromide
and visualized under UV light using computer video.
The distribution of genotypes of polymorphic loci
studied by checking for compliance with Hardy-
Weinberg equilibrium using the criterion χ2. To test
the significance of the overall extent of commu-
nication nonparametric test of Pearson (χ2) and the
figure odds ratio (OR) were used. Statistical analysis
of the data was performed using computer software
package "Statistica 6.0".
Results and discussion
Estimation of the distribution of polymorphism
gene IL-1β -511C/T showed that risk of ulcer is
associated with the presence of low productive allele
IL-1β-511*C and homozygous genotype IL-1β-511C/
C (OR = 2,90, [1,99-4,24] and OR = 6,47, [3,53-
11,84], respectively) in children in the population of
Chernivtsi region. In its turn high productive allele IL-
1β-511*T heterozygous genotype and IL-1β-511C/T
and exhibit protective effect associated with a
reduced risk of developing the disease (OR = 0,34,
[0,24-0,50] and OR = 0,26 [0,15-0,44], respectively).
Analysis of the distribution of genotypes and alleles of
the gene IL-1β-511C/T in children of the basic group
according to age and course of the disease found no
probable associative connections.
Allele R4 IL-1Ra (χ2 = 28,21, p<0,0001) pre-
valence was registered among children of the main
group whereas allele R2 IL-1Ra (p<0,05) occurred
significantly more frequent in children of comparison
group. Homozygous genotype R4/R4 IL-1Ra (32,0
% and 47,3 %, χ2 = 5,82, p<0,01) dominated likely in
sick individuals. Instead of, in children of the com-
parison group homozygous genotype R2/R2 IL-1Ra
(34,0 % and 12,7 %, χ2 = 16,35,  p<0,0001) was
diagnosed more often.
Thus, allele R4 IL-1Ra (OR = 2,21, [1,32-3,71])
and genotype R4/R4 IL-1Ra (OR = 1,91, [1,12-3,24])
can serve as predictors of the risk of duodenum ulcer
disease in children. Allele R2 IL-1Ra (OR = 0,44,
[0,26-0,75]) and the genotype of R2/R2 IL-1Ra (OR
= 0,28, [0,15-0,53]) proved to be protective factors.
It should be noted that the indirect reaction as to
IL-1β and IL-1Ra, which cause destructive pro-
cesses depend on the combination of genotypes of
polymorphic loci persons relevant genes [4]. In this
connection, it has been set the frequency of detection
of haplotypes different combinations in patients and
healthy children.
It has been established that the risk of ulcer
increase 5,52 times in the presence of combinations
of genotypes IL-1β-511C/C and R4/R4 IL-1Ra (OR
= 5,52, [2,65-11,47]) and 3,48 times in the registration
haplotype IL-1β-511C/C and R2/R4 IL-1Ra (OR =
3,48, [1,15-10,56]). Haplotype IL-1β-511C/T and R2/
R2 IL-1Ra can serve as a marker of resistance to
disease development in children (OR = 0,09, [0,03-
0,24]).
Significant difference in the distribution of hap-
lotype frequencies of genes IL-1β-511C/T and IL-
1Ra, depending on the age and course of the disease
we have not found.
Role of allelic variants of the gene polymorphisms
IL-8-251A/T in the pathogenesis of ulcer is not am-
biguous. The allele IL-8-251*A is considered to be
associated with progression of atrophic changes in
MM, which increases the risk of ulcer in the Korean
population [8], other researchers have shown a
relationship between carrier genotype IL-8-251T/T
and development of duodenal ulcers [11].
In this study it has been found that in children of
the main group frequency of "mutant" allele IL-8-
251*A is significantly higher and frequency of "wild"
allele of IL-8-251*T is significantly lower than in the
comparison group (50,3 % and 24,0 % and 49,7 %
and 76,0 %, respectively, χ2 = 34,73, p <0,0001).
Heterozygous genotype of IL-8-251A/T is 2,3 times
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more often found in children with UD, which was
significantly higher with respect to its frequency in the
healthy group (χ2 = 28,96, p<0,001). However, ho-
mozygous for the "wild" allele genotype of IL-8-
251T/T was diagnosed in patients of the main group
3,3 times less likely than in children of the comparison
group (χ2 = 49,19, p <0,001).
Thus, "mutant" allele of IL-8-251*A (OR = 3,21
[2,16-4,77]) and heterozygous genotype of IL-8-
251A/T (OR = 4,39 [2,52 -7,64]) are prognostic mar-
ker of risk of ulcer and the presence of "wild" allele
of IL-8-251*T (OR = 0,31 [0,21-0,46]) and homo-
zygous genotype IL-8-251T/T (OR = 0,14 [0,08-
0,25]) may serve as protective markers of  the di-
sease development.
"Mutant" allele of IL-8-251*A and homozygous
genotype IL-8-251A/A are adverse prognostic fea-
tures, which can increase the risk of ulcer in boys
(OR = 1,72 [1,09-2,72] and OR = 2,75 [1,14-6,67],
respectively).
To determine the relationship of different poly-
morphic variants of the gene with the development of
ulcer attention should be paid to systems of intergene
interaction.
It has been determined that the combination of
IL-1β -511C/C, R4/R4 IL-1Ra, IL-8-251A/T (χ2 =
27,97, p <0,001) risk of the disease will increased 19,1
times (OR = 19,1 [4,49-80,8]); IL-1β-511C/C, R4/R4
IL-1Ra, IL-8-251A/A and IL-1β-511C/C, R2/R4 IL-
1Ra, IL-8-251A/T - 6,32 times (OR = 6,32, [0,79-
50,7]). The risk will be the smallest in case of
combination of the following genotypes: IL-1β-511C/
T, R2/R2 IL-1Ra, IL-8-251T/T (OR = 0,02, [0,00-
0,18]).
Taking into consideration the importance and rele-
vance of NO significance in the pathology of gast-
rointestinal tract molecular genetic study of children
with UD has been carried out - namely G954C poly-
morphism i-NOS promoter gene for single nucleotide
replacement was identified [10].
"Wild" allele G and genotype GG was met with
almost equal frequency in children in both groups
(p>0,05). Thus the indices of OR were less than
one, indicating a possible protective effect of the
allele and genotype.
In patients with PUD the mutant allele C occu-
rred 2 times, and GC genotype in 1,83 times more
often than in practically healthy children; genotype
CC - only in children of the main group. Analysis of
epidemiological indices of OR showed that probability
of the disease development increases by 1,3 times
(95% CI [0,52-3,29], χ2 = 8,41, p = 0,012) in the pre-
sence of GC genotype and 3,9 times (95% CI [0,21-
73,83], χ2 = 9,6, p = 0,0007) in the case of genotype
CC. It should be noted that genotype CC was diag-
nosed in children with complicated course of ulcer.
The frequency distribution of genotypes according
to sex, in general, was almost the same as for the
children of the main group and the comparison group
of persons.
Thus, the identification of patterns of implemen-
tation allelic variants of polymorphism gene of in-
terleukins and induced NO-synthase is an important
link disorder of immunoreactivity of macroorganism in
the pathogenesis of helicobacter-associated ulcer,
whose development is the result of molecular genetic
determination of the immune system.
Conclusions
1. Factor increased risk of peptic ulcer disease in
children Chernivtsi region is carrier genotypes genes
IL-1β -511C/C, R4/R4 IL-1Ra, IL-8-251A/T R4 and
CC i-NOS G954C. The highest risk of disease
observed in the combination of the above genotypes
of interleukin genes.
2. Genotype genes IL-1β -511C/T, R2/R2 IL-
1Ra, IL-8-251T/T genotype and their combination
CC G954C i-NOS may serve as protectors of deve-
lopment of peptic ulcer in children of Chernivtsi re-
gion.
Prospects for further research
Prospects for future research are to develop a
unified algorithm for diagnosis and prognosis of the
development and course of peptic ulcer disease in
children, that in its turn will allow to carry out dif-
ferentiated genotype-specific treatment of nosology.
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ÂÏËÈÂ ÀËÅËÜÍÈÕ ÂÀÐ²ÀÍÒ²Â ÏÎË²ÌÎÐÔÍÈÕ
ÃÅÍ²Â ²ÍÒÅÐËÅÉÊ²Í²Â, ²ÍÄÓÊÎÂÀÍÎ¯ ÑÈÍÒÀÇÈ
ÌÎÍÎÎÊÑÈÄÓ Í²ÒÐÎÃÅÍÓ ÒÀ ¯ Õ ÐÅÖÅÏÒÎÐ²Â ÍÀ
ÏÅÐÅÁ²Ã ÃÅË²ÊÎÁÀÊÒÅÐ-ÀÑÎÖ²ÉÎÂÀÍÎ¯
ÂÈÐÀÇÊÎÂÎ¯ ÕÂÎÐÎÁÈ Ó Ä²ÒÅÉ
Ò.Â. Ñîðîêìàí, Ñ.Â. Ñîêîëüíèê, Ä.Ð. Àíäð³é÷óê
Ðåçþìå. Â ñòàòò³ íàâåäåíî ðåçóëüòàòè àíàë³çó ðîçïîä³ëó
àëåëüíîãî ïîë³ìîðô³çìó ãåí³â ³íòåðëåéê³í³â-1áåòà, -8,
ðåöåïòîðíîãî àíòàãîí³ñòà ³íòåðëåéê³íà-1 òà ³íäóêîâàíî¿ NO-
ñèíòàçè â ä³òåé ×åðí³âåöüêî¿ îáëàñò³, õâîðèõ íà âèðàçêîâó
õâîðîáó øëóíêà òà äâàíàäöÿòèïàëî¿ êèøêè, òà çäîðîâèõ.
Âñòàíîâëåíî, ùî ñõèëüí³ñòü äî âèðàçêîâî¿ õâîðîáè àñî-
ö³þºòüñÿ ç íàÿâí³ñòþ íàñòóïíèõ ãåíîòèï³â: IL-1β-511Ñ/Ñ, R4/
R4 IL-1Ra, IL-8-251À/Ò òà Ñ/Ñ G954Ñ ó ïðîìîòîðí³é çîí³
ãåíà ³íäóêîâàíî¿ NO-ñèíòàçè.
Êëþ÷îâ³ ñëîâà: ä³òè, âèðàçêîâà õâîðîáà, àëåëüíèé
ïîë³ìîðô³çì ³ìóíîðåãóëÿòîðíèõ öèòîê³í³â, ³íäóêîâàíà NO-
ñèíòàçà.
ÂËÈßÍÈÅ ÀËËÅËÜÍÛÕ ÂÀÐÈÀÍÒÎÂ
ÏÎËÈÌÎÐÔÍÛÕ ÃÅÍÎÂ ÈÍÒÅÐËÅÉÊÈÍÎÂ,
ÈÍÄÓÖÈÁÅËÜÍÎÉ ÑÈÍÒÀÇÈ ÌÎÍÎÎÊÑÈÄÀ
Í²ÒÐÎÃÅÍÀ È ÈÕ ÐÅÖÅÏÒÎÐÎÂ ÍÀ ÒÅ×ÅÍÈÅ
ÕÅËÈÊÎÁÀÊÒÅÐ-ÀÑÑÎÖÈÈÐÎÂÀÍÎÉ ßÇÂÅÍÍÎÉ
ÁÎËÅÇÍÈ Ó ÄÅÒÅÉ
Ò.Â. Ñîðîêìàí, Ñ.Â. Ñîêîëüíèê, Ä.Ð. Àíäðåé÷óê
Ðåçþìå. Â ñòàòüå îïèñàíû ðåçóëüòàòû àíàëèçà ðàñï-
ðåäåëåíèÿ àëëåëüíîãî ïîëèìîðôèçìà ãåíîâ èíòåðëåéêèíîâ-
1áåòà, -8, ðåöåïòîðíîãî àíòàãîíèñòà èíòåðëåéêèíà-1 è
èíäóöèáåëüíîé NO-ñèíòàçû ó äåòåé ×åðíîâèöêîé îáëàñòè,
áîëüíûõ ÿçâåííîé áîëåçíüþ æåëóäêà è äâåíàäöàòèïåðñòíîé
êèøêè, è çäîðîâûõ. Óñòàíîâëåíî, ÷òî ïðåäðàñïîëîæåííîñòü
ê ÿçâåííîé áîëåçíè àññîöèèðóåòñÿ ñ íàëè÷èåì ñëåäóþùèõ
ãåíîòèïîâ: IL-1β-511Ñ/Ñ, R4/R4 IL-1Ra, IL-8-251À/Ò è Ñ/Ñ
G954Ñ â ïðîìîòîðíîé çîíå ãåíà èíäóöèáåëüíîé NO-ñèí-
òàçû.
Êëþ÷åâûå ñëîâà: äåòè, ÿçâåííàÿ áîëåçíü, àëëåëüíûé
ïîëèìîðôèçì èììóíîðåãóëÿòîðíûõ öèòîêèíîâ, èíäóöè-
áåëüíàÿ NO-ñèíòàçà.
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